Asserter profile
OAKTREE FUND ADMINISTRATION, LLC
operating company0 patents now2 ever0 cases filed during tenure2 connections
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
Noaktree_fund_administration["OAKTREE FUND ADMINISTRATION, LLC"]
Nmesoblast_s_rl_mesoblast_acn_109_431_870_mesoblast_uk_mesobl["MESOBLAST INTERNATIONAL SÀRL, MESOBLAST…"]
Nmesoblast_sarl_mesoblast_acn_109_431_870_mesoblast_uk_mesobl["MESOBLAST INTERNATIONAL SARL; MESOBLAST…"]
Nmesoblast_s_rl_mesoblast_acn_109_431_870_mesoblast_uk_mesobl -->|"2021 · SECURITY INTEREST · 8637004"| Noaktree_fund_administration
Nmesoblast_sarl_mesoblast_acn_109_431_870_mesoblast_uk_mesobl -->|"2021 · SECURITY INTEREST · 11708560"| Noaktree_fund_administration
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class Noaktree_fund_administration focal
class Nmesoblast_s_rl_mesoblast_acn_109_431_870_mesoblast_uk_mesobl operating
class Nmesoblast_sarl_mesoblast_acn_109_431_870_mesoblast_uk_mesobl operating
Patents previously held (2)
- US 86370042021-12-09 → 2025-07-30
- US 117085602021-12-10 → 2026-01-02
Connected entities (2)
- MESOBLAST INTERNATIONAL SÀRL, MESOBLAST LIMITED ACN 109 431 870, MESOBLAST UK LIMITED, MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.)operating company1 patent
- MESOBLAST INTERNATIONAL SARL; MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.)operating company1 patent
Correspondent attorneys (2)
Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.
- (no name)· PROSKAUER ROSE1 appearance
- JASON C. VOGEL· LATHAM & WATKINS1 appearance